Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 9, 2006, Pages 985-990

  Ichiki, Hitoshi ^a   Oketani, Naoya ^a   Hamasaki, Shuichi ^a   Ishida, Sanemasa ^a   Kataoka, Tetsuro ^a   Ogawa, Masakazu ^a   Saihara, Keishi ^a   Okui, Hideki ^a   Fukudome, Tsuyoshi ^a   Shinasato, Takuro ^a   Kubozono, Takuro ^a   Ninomiya, Yuichi ^a   Matsushita, Takehiko ^a   Otsuji, Yutaka ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

BNP; Left ventricular function; Pacemaker; Right ventricular function; Tei index; Ventricular apex pacing

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART RATE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE EJECTION TIME; HUMAN; MAJOR CLINICAL STUDY; MALE; SICK SINUS SYNDROME; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIAC PACING, ARTIFICIAL; EQUIPMENT FAILURE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PACEMAKER, ARTIFICIAL; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 33748684608     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00474.x     Document Type: Article

References (31)

1. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102:3053-3059.
2. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26:357-366.
3. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: Correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10:169-178.
4. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28:658-664.
5. Dujardin KS, Tei C, Yeo TC, Hodge DO, Rossi A, Seward JB. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 1998; 82:1071-1076.
6. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide, and brain natriuretic peptide. J Clin Invest 1991; 87:1402-1412.
7. Zhang Q, Yu Z, Xue X. Influence of different right cardiac pacing site in the plasma levels of atrial natriuretic factor (ANF) in patients with bradyarrhythmias. Pacing Clin Electrophysiol 1999: 22 (abstract).
8. Toda N, Ishikawa T, Tsunematsu T, et al. Crossover comparison of the effects of DDD and VVI in plasma level of B-type natriuretic peptide. Pacing Clin Electrophysiol 1999: 22 (abstract).
9. Seino Y, Shimai S, Nagae Y, Ibuki C, Takano T, Tanaka S, Hayakawa H. Cardiodynamic and neurohormonal importance of atrial contribution in rate-responsive pacing. Am J Cardiol 1993; 72:36-40.
10. Drake-Holland AJ, Noble MI. Neural-natriuretic hormone interactions. Eur Heart J 2000; 21:424-426.
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
12. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
13. Arcilla RA, Thilenius OG, Chiemmongkoltip P, Ranniger K. Left atrial volume calculation by angiocardiography in children. Chest 1973; 63:189-197.
14. Ren JF, Kotler MN, DePace NL, Mintz GS, Kimbiris D, Kalman P, Ross J. Two-dimensional echocardiographic determination of left atrial emptying volume:Anoninvasive index in quantifying the degree of nonrheumatic mitral regurgitation. J Am Coll Cardiol 1983; 2:729-736.
15. Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction, and the difference in duration of pulmonary venous andmitral flow velocity at atrial contraction. J Am Coll Cardiol 1993; 22:1972-1982.
16. Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: Important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001; 76:467-475.
17. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995; 26:135-136.
18. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96:509-516.
19. Fujino M, Arakawa K. Echocardiographic assessment of left ventricular function in patients with complete left bundle branch block. Jpn Circ J 1984; 48:119-126.
20. Dudek D, Rzeszutko L, Petkow Dimitrow P, et al. Circulating N-terminal brain natriuretic peptide precursor and endothelin levels in patients with syndrome X and left bundle branch block with preserved systolic function. Int J Cardiol 2001; 79:25-30.
21. Kürüm T, Yüksel M, Özbay G, Söyük S, Türe M. Relationship with plasma neurohormones and detected by Doppler echocardiography in patients undergoing permanent pacemaker implantation. Acta Cardiol 2003; 58:499-505.
22. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332:78-81.
23. Mukoyama M, Nakao K, Saito Y, et al. Human brain natriuretic peptide, a novel cardiac hormone. Lancet 1990; 335:801-802.
24. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 1991; 17:1152-1155.
25. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990; 65:903-908.
26. Lang CC, Choy AM, Khong TK, Motwani JG, Stuthors AD. Brain natriuretic peptide: Its release and metabolism in man. Circulation 1991; 84 (Suppl. II): 108.
27. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 1985; 314:264-266.
28. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K. Increased plasma levels of brain natriuretic peptide in acute myocardial infarction. Circulation 1993; 88:82-91.
29. Okawa M, Kitaoka H, Matsumura Y, Kubo T, Yamasaki N, Furuno T, Doi Y. Functional assessment by myocardial performance index (Tei index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy. Circ J 2005; 69:951-957.
30. Ono M, Tanabe K, Asanuma T, Yoshitomi H, Shimizu H, Ohta Y, Shimada T. Doppler echocardiography-derived index of myocardial performance (TEI index): Comparison with brain natriuretic peptide levels in various heart disease. Jpn Circ J 2001; 65:637-642.
31. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, Mode selection trial investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107:2932-2937.